SCHEMBL762525

SCHEMBL762525

CNP(=O)(O)C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3071835 0.78 MMP1 (0.38)
SCHEMBL739862 0.73 ALDH1A1 (0.43)
SCHEMBL3071224 0.69 LAP3 (0.35)
SCHEMBL440980 0.68
SCHEMBL240710 0.68
SCHEMBL3062832 0.67 CA12 (0.31)
SCHEMBL11995816 0.65
SCHEMBL17626543 0.65 LAP3 (0.47)
Hydrochloric Acid SCHEMBL10904960 0.65
SCHEMBL17626398 0.65 LAP3 (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138154-B2 Biglycan and related therapeutics and methods of use BROWN UNIVERSITY RESEARCH FOUNDATION (US) 2012-03-20 US disclosed
US-20100130405-A1 BIGLYCAN AND RELATED THERAPEUTICS AND METHODS OF USE BROWN TECHNOLOGY PARTNERSHIPS (US) 2010-05-27 US disclosed